PAVmed (PAVM)
Building digital oncology, esophageal diagnostics, and medical-device platforms through a shared-services model.
$5.28
Pre-market−0.37 (−6.55%)
At close$5.65(+13.23%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions20 holders · as of Mar 31, 2026 | 8.02% | 512.1K shares | |
| Insiders13 holders · as of Apr 13, 2026 | 35.09% | 2.24M shares | |
| Strategic holders1 holder · as of Apr 6, 2026 | 14.30% | 913.0K shares | |
| Otherremainder | 42.59% | 2.72M shares |
6.38M company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (8.00M in the company's Sep 3, 2026 report, 6.38M elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
20 holders · 512.1K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Two Seas Capital LP | 461.5K | 7.23% | May 15, 2026 | |
| First Manhattan Co. LLC. | 23.8K | 0.37% | May 15, 2026 | |
| Geode Capital Management, LLC | 11.8K | 0.18% | May 15, 2026 | |
| Vanguard Capital Management LLC | 5.9K | 0.09% | May 15, 2026 | |
| Vanguard Fiduciary Trust Co | 5.4K | 0.09% | May 8, 2026 | |
| BlackRock, Inc. | 2.4K | 0.04% | May 13, 2026 | |
| Tower Research Capital LLC (TRC) | 622 | 0.01% | May 15, 2026 | |
| Morgan Stanley | 165 | 0.00% | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tasso Partners, LLC | 18.90% | 13G | Feb 28, 2025 ↗ | |
| Two Seas Capital LP | 9.99% | 657.2K | 13G | May 15, 2026 ↗ |
| Ayrton Capital LLC | 9.99% | 709.1K | 13G | May 11, 2026 ↗ |
| Scopia Holdings LLC | 9.90% | 630.1K | 13G | Apr 13, 2026 ↗ |
| First Manhattan Co. LLC. | 9.60% | 639.2K | 13G | May 14, 2026 ↗ |
| Nagelberg David S | 8.60% | 547.0K | 13G | Apr 8, 2026 ↗ |
| Kallman Craig | 6.00% | 384.6K | 13G | Apr 3, 2026 ↗ |
| Sargent Investment Group, LLC | 5.80% | 13G | Aug 14, 2025 ↗ | |
| Dubrevilleincl. Family Trust | 5.50% | 13G | Sep 23, 2024 ↗ | |
| Dols Scott V. | 5.40% | 346.2K | 13G | Apr 8, 2026 ↗ |
| Aklog Lishan | 5.10% | 369.1K | 13D | Apr 9, 2026 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.